University of California researchers have discovered the presence of marker compounds from Gram-negative bacteria--including Escherichia coli--in brain tissue from people with Alzheimer's disease, providing further support for the notion that there is a microbial component in the etiology of this common form of dementia.
Alzheimer’s affects about 5.4 million Americans, and that number is expected to rise. In part, it’s being driven by the rampant prevalence of diabetes.The epidemiology is clear: people with type 2 diabetes are nearly twice as likely to develop Alzheimer’s as non-diabetics.
People who take Benadryl every night to sleep should probably think seriously about an alternative method….if they can remember to do so. A recent report published in JAMA Internal Medicine, provides convincing evidence that frequent and long-term use of anticholinergic drugs like Benadryl raise the risk of dementia.
Contrary to public expectations, consumption of diet sodas might actually be causing weight gain, rather than promoting weight loss. According to a recent study from the University of Texas, we may be able to fool our tastebuds, but we cannot fool our microbiomes.
The combination of chondroitin and glucosamine may be as effective as a commonly prescribed NSAID in treating painful knee osteoarthritis, according to data from a large multicenter trial headed by investigators at the University of Maryland.
B vitamins are widely promoted for the treatment and prevention of many forms of dementia. But new research raises questions about the efficacy of B vitamins for slowing cognitive decline.
Daily supplementation with plant-derived carotenoids can reduce the risk of age-associated macular degeneration, and may also have a role in prevention of Alzheimer's disease, according to James Stringham, PhD, of the Nutritional Neuroscience Laboratory at the University of Georgia, Atlanta.
It's no secret that medication management is a major health concern for seniors.
For generations, the prevailing medical wisdom has been that neurodegeneration is irreversible, and that adults simply cannot re-grow lost or damaged neurons.
A new injection-based modality that uses the body’s own cytokines to reduce joint inflammation was recently introduced in the US, and it has great promise for relieving joint pain, back pain, tendonitis and other symptoms of osteoarthritis (OA).